Mutant presenilin 2 increased oxidative stress and p53 expression in neuronal cells

被引:16
|
作者
Nguyen, Hong Nga
Lee, Moon Soon
Hwang, Dae Youn
Kim, Young Kyu
Yoon, Do Young
Lee, Jae Woong
Yun, Yeo Pyo
Lee, Myung Koo
Oh, Ki Wan
Hong, Jin Tae
机构
[1] Chungbuk Natl Univ, CBITRC, Coll Pharm, Chungbuk 361763, South Korea
[2] Natl Inst Environm Res, Inchon 404780, South Korea
[3] Korea Food & Drug Adm, Natl Inst Toxicol Res, Seoul 122704, South Korea
[4] Konkuk Univ, Div Biosci & Biotechnol, Lab Cell & Immunobiochem, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
neuronal cell; presenilin; 2; 8-oxodG; p53; Alzheimer's disease;
D O I
10.1016/j.bbrc.2007.03.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The learning and memory impairment of presenifin 2 transgenic mice was mentioned previously. In this study, exposing the presenifin 2 transfected PC12 cells to the 50 mu M A beta(25-35), 30 mM L-glutamate and 50 mu M H2O2 resulted in significant increase 8-oxodG and p53 levels of the cells expressing the mutant gene. The increase was also found in the mutant presenilin 2 transgenic mice brains age-dependently in comparison to that in the wild-type presenilin 2-transgenic mice and non-transgenic ones. These findings indicated that mutant presenilin 2 clearly increases oxidative stress and p53 expression, which could be implicated in promoting mutant presenilin 2-induced neurodegeneration in Alzheimer's disease, and the influence of mutant presenilin 2 in Alzheimer's disease may be brain regional and age related effects. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 50 条
  • [41] p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53
    H Yan
    V Solozobova
    P Zhang
    O Armant
    B Kuehl
    G Brenner-Weiss
    C Blattner
    Cell Death & Disease, 2015, 6 : e1662 - e1662
  • [42] p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53
    Yan, H.
    Solozobova, V.
    Zhang, P.
    Armant, O.
    Kuehl, B.
    Brenner-Weiss, G.
    Blattner, C.
    CELL DEATH & DISEASE, 2015, 6 : e1662 - e1662
  • [43] Mutant p53 and mTOR/PKM2 regulation in cancer cells
    Dando, Ilaria
    Cordani, Marco
    Donadelli, Massimo
    IUBMB LIFE, 2016, 68 (09) : 722 - 726
  • [44] Increased apoptosis induction by 121F mutant p53
    Saller, E
    Tom, E
    Brunori, M
    Otter, M
    Estreicher, A
    Mack, DH
    Iggo, R
    EMBO JOURNAL, 1999, 18 (16): : 4424 - 4437
  • [45] p53 in neuronal apoptosis
    Culmsee, C
    Mattson, MP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) : 761 - 777
  • [46] MUTANT P53 EXPRESSION IN GASTRIC CARCINOMAS IS A PROGNOSTIC INDICATOR
    FILIPE, MI
    MARTIN, MH
    LANE, DP
    GUT, 1991, 32 (10) : A1237 - A1237
  • [47] MUTANT P53 EXPRESSION IN SOLAR KERATOSIS - AN IMMUNOHISTOCHEMICAL STUDY
    SIM, CS
    SLATER, S
    MCKEE, PH
    JOURNAL OF CUTANEOUS PATHOLOGY, 1992, 19 (04) : 302 - 308
  • [48] Proteasome inhibitors suppress the protein expression of mutant p53
    Halasi, Marianna
    Pandit, Bulbul
    Gartel, Andrei L.
    CELL CYCLE, 2014, 13 (20) : 3202 - 3206
  • [49] EXPRESSION OF MUTANT P53 PROTEIN IN HEPATOCELLULAR-CARCINOMA
    COLLIER, JD
    CARPENTER, M
    BURT, AD
    BASSENDINE, MF
    GUT, 1994, 35 (01) : 98 - 100
  • [50] Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function
    Zhao, Yuhan
    Yue, Xuetian
    Hu, Wenwei
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)